Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma.
Liam G HeaneyJohn BusbyPeter BraddingRekha ChaudhuriAdel H MansurRobert NivenIan D PavordJohn T LindsayRichard W Costellonull nullPublished in: American journal of respiratory and critical care medicine (2020)
Remote FeNO suppression testing is an effective means of identifying nonadherence to ICS in subjects with difficult-to-control asthma and the substantial population of subjects who derive important clinical benefits from optimized ICS/long-acting β2-agonist treatment.